Answers are grounded in this paper and cite their sources.
Antibiotic resistance (ABR) is a major public health crisis that undermines the effectiveness of modern medicine worldwide. This narrative review synthesizes recent evidence on the global burden, mechanisms, drivers, and clinical implications of ABR, emphasizing its One Health context. We performed a comprehensive literature review (2019–2025) of peer-reviewed studies, reports, and surveillance data. Findings indicate that antibiotic-resistant infections caused an estimated 1.27 million deaths in 2019 and were associated with nearly 5 million deaths globally. The highest burden occurs in low- and middle-income regions, where limited healthcare resources and lax regulation fuel resistant strains. Resistance mechanisms are diverse, including drug inactivation, efflux pumps, target modification, and biofilm formation, reflecting antibiotic use as an ancient bacterial survival strategy. Key drivers include inappropriate antibiotic use in human and veterinary medicine, agricultural use for growth promotion, and environmental contamination from pharmaceutical waste. Clinically, resistance has rendered common infections harder to treat and has made routine surgeries and treatments (e.g., chemotherapy, transplants) riskier. The economic impact is substantial, with projected multi-trillion-dollar losses by 2030. Our review highlights One Health stewardship strategies – infection prevention, optimized antibiotic use, new diagnostics and vaccines, and global cooperation - as essential to curbing ABR. Urgent action is required to preserve antibiotic efficacy for future generations.
No takes yet. Share an insight, caveat, or question.
Matsiusheuskaya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: